Cargando…
Review Article: vaccination for patients with inflammatory bowel disease during the COVID‐19 pandemic
BACKGROUND: Poor immune responses are frequently observed in patients with inflammatory bowel disease (IBD) receiving established vaccines; risk factors include immunosuppressants and active disease. AIMS: To summarise available information regarding immune responses achieved in patients with IBD re...
Autores principales: | Doherty, Jayne, Fennessy, Sean, Stack, Roisin, O’ Morain, Neil, Cullen, Garret, Ryan, Elizabeth J., De Gascun, Cillian, Doherty, Glen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653045/ https://www.ncbi.nlm.nih.gov/pubmed/34472643 http://dx.doi.org/10.1111/apt.16590 |
Ejemplares similares
-
Severe Symptomatic Primary CMV Infection in Inflammatory Bowel Disease Patients with Low Population Seroprevalence
por: Rowan, Catherine, et al.
Publicado: (2018) -
Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION)
por: Doherty, Jayne, et al.
Publicado: (2022) -
Implementation of BSG/ACPGBI/PHE polypectomy surveillance guidelines safely reduces the burden of surveillance in a screening cohort: a virtual model study
por: Stack, Roisin, et al.
Publicado: (2023) -
Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease
por: Zaiatz Bittencourt, Vanessa, et al.
Publicado: (2021) -
A stalk with no polyp—A muco‐submucosal elongated polyp in the duodenum
por: O’Morain, Neil, et al.
Publicado: (2023)